O'Mahony James J JJ

OmicsDI

Browse
Submit Data
Databases
API

3 Results

Show all Save search Copy query

Show results for

Unknown (3)

Publication Date

Release Date

2008 (3)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Background

The treatment of ischaemic stroke with neuroprotective drugs has been unsuccessful, and whether these compounds can be used to reduce disability after recurrent stroke is unknown. The putative neuroprotective effects of antiplatelet compounds and the angiotensin II receptor antago...

S-EPMC2772657 | biostudies-literature

Telmisartan to prevent recurrent stroke and cardiovascular events.

Background

Prolonged lowering of blood pressure after a stroke reduces the risk of recurrent stroke. In addition, inhibition of the renin-angiotensin system in high-risk patients reduces the rate of subsequent cardiovascular events, including stroke. However, the effect of lowering of blood ...

S-EPMC2714258 | biostudies-literature

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

Background

Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel.